2025 San Antonio Breast Cancer Symposium: Maintenance Therapy Updates in Metastatic HER2+ Breast Cancer

from Medical News Podcast · host PeerDirect Publishing

Drs. Isaacs and Traina review how HER2CLIMB‑05 and PATINA challenge the old CLEOPATRA‑based approach by showing that adding tucatinib or palbociclib to maintenance therapy can extend progression‑free survival in metastatic HER2+ breast cancer. They stress tailoring maintenance regimens to each patient’s hormone receptor status, CNS risk, and tolerance for side effects.

Episode metadata supplied by the publisher feed · Published Mar 12, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

2025 San Antonio Breast Cancer Symposium: Maintenance Therapy Updates in Metastatic HER2+ Breast Cancer

0:00 12:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 12 minutes long.

When was this Medical News Podcast episode published?

This episode was published on March 12, 2026.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!